Targeting DNGR‐1 with Fangchinoline Elevates Dendritic Cell Antigen Cross‐Presentation‐Mediated Antitumor Immunity in Melanoma
Advanced Science · 2026
DOI: 10.1002/advs.76043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Yuan Liao und 19 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Integrative Medicine, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China. Hauptthemen laut MEDLINE: Benzylisoquinolines, Dendritic Cells, Cross-Priming, Melanoma. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Science and Technology Plan Project of Guangzhou of China.
Abstract (Originalsprache)
Cross‐presentation of exogenous antigens by dendritic cells (DCs) is essential for initiating CD8 + T cell–mediated anti‐tumor immunity. DNGR‐1 (CLEC9A), a C‐type lectin receptor on conventional type 1 DCs (cDC1s), facilitates uptake and cytosolic delivery of dead cell–associated antigens. However, no small‐molecule modulators of DNGR‐1 have been reported. Here, we identify fangchinoline—a natural bisbenzylisoquinoline alkaloid—as a small‐molecule modulator that enhances antigen cross‐presentation in a DNGR‐1‐dependent manner. Functional screening shows fangchinoline promotes MHC‐I–restricted cross‐presentation and CD8 + T cell priming. It binds a DNGR‐1 pocket (Trp209, Glu225, Arg226), confirmed by surface plasmon resonance, thermal shift, probe labeling, and mutagenesis. DNGR‐1 engagement activates the Syk–Nox2 pathway, increasing phagosomal reactive oxygen species and membrane permeabilization to enable cytosolic antigen access. Fangchinoline exerts subset‐dependent effects: in GM‐CSF/IL‐4–derived DCs and endogenous cDC1‐associated settings in vivo, it enhances cross‐presentation‐associated function, whereas in Flt3L‐induced DCs with high basal DNGR‐1 expression it promotes DNGR‐1‐dependent cell death. In melanoma models, fangchinoline synergizes with DC transfer and PD‐1 blockade to promote CD8 + T cell–mediated tumor control. It enhances antigen‐specific CD8 + T cell activation in human DC–T cell co‐cultures. Together, these findings establish fangchinoline as a DNGR‐1‐targeting modulator for context‐dependent enhancement of anti‐tumor immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center of Integrative Medicine, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.
- Department of Biochemistry, Guangzhou University of Chinese Medicine, Guangzhou, China.
- Research Center of Integrated Chinese and Western Medicine, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China.
- Department of Pathology and Pathophysiology, Guangzhou University of Chinese Medicine, Guangzhou, China.
- Zhongshan Hospital of Traditional Chinese Medicine Affiliated to Guangzhou University of Chinese Medicine, Zhongshan, China.
- Department of Laboratory Medicine, Meishan Tianfu New Area People's Hospital, Meishan, China.
ORCID-Profile: Yao Wang, Jiangyong Gu, Fang Liu, Kun Wang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Science and Technology Plan Project of Guangzhou of China
Zitieren
APA
Liao, Y., Ren, Z., Zhou, J., Luo, H., Li, Y., Chen, D., Jiang, Y., Li, C., Zheng, M., Li, A., Wang, Y., Zhang, Y., Wang, D., Jiang, Y., Gu, J., Du, B., Shi, Y., Liu, F., Xiao, J., & Wang, K. (2026). Targeting DNGR‐1 with Fangchinoline Elevates Dendritic Cell Antigen Cross‐Presentation‐Mediated Antitumor Immunity in Melanoma. Advanced Science. https://doi.org/10.1002/advs.76043
Vancouver
Liao Y, Ren Z, Zhou J, Luo H, Li Y, Chen D, et al. Targeting DNGR‐1 with Fangchinoline Elevates Dendritic Cell Antigen Cross‐Presentation‐Mediated Antitumor Immunity in Melanoma. Advanced Science. 2026. doi:10.1002/advs.76043
BibTeX
@article{Liao2026,
author = {Liao, Yuan and Ren, Zhenyang and Zhou, Jing and Luo, He and Li, Yuling and Chen, Dan and Jiang, Yuxiao and Li, Canzhe and Zheng, Mengyi and Li, Anqi and Wang, Yao and Zhang, Yang and Wang, Dingye and Jiang, Yanjun and Gu, Jiangyong and Du, Biaoyan and Shi, Yafei and Liu, Fang and Xiao, Jianyong and Wang, Kun},
title = {Targeting DNGR‐1 with Fangchinoline Elevates Dendritic Cell Antigen Cross‐Presentation‐Mediated Antitumor Immunity in Melanoma},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.76043}
}
EUVIMED